Within the past decade, it has become apparent that the pathogenesis of IDDM is a progressive autoimmune destruction of pancreatic beta cells that precedes, by several years, the development of end organ failure. There exist two ways to deal clinically with IDDM. The first is to prevent the autoimmune destruction of the pancreatic beta cells prior to overt disease and the second is to attempt to replace beta cell function by beta cell transplantation or by hormone replacement (insulin). In this grant application, we propose to utilize allogeneic bone marrow hematopoietic stem cell isolation and transplantation into spontaneously autoimmune non- obese diabetic (NOD) mice in attempts to generate chimeric NOD mice that express both their own bone marrow elements and the additional bone marrow- derived cells from the allogeneic donor. Stem cell transplants differ from whole bone marrow grafts in that, although stem cells give rise to all hematolymphoid lineages, they are immature, """"""""uneducated"""""""" precursors of lymphoid cells and thus when transplanted do not elicit graft vs. host disease (GVHD). GVHD remains a major obstacle to the clinical use of bone marrow transplantation. This type of transplantation can serve two functions: First, successful stem cell engraftment might alter the recipient's immune system in such a way that the presence of the allogeneic lymphohematopoietic cells might confer protection against the host's own autoimmune response against islet beta cells. To test this, we plan to transplant NOD mice at a young age before they have developed massive beta cell destruction to determine if bone marrow chimerism will block the induction or perpetuation of insulitis and resultant hyperglycemia. Secondly, successful stem cell transplantation and resultant chimerism may alter the recipient's immune system's ability to respond against tissue from the donor. Thus, a chimeric NOD mouse may be able to accept islets, as well as other tissue transplants, from the donor strain of the hematopoietic stem cell transplant without the need for immunosuppression. The studies in this grant application propose a systematic approach to minimize immunosuppressive regimens and decrease morbidity associated with bone marrow transplantation as it specifically could apply to Type I diabetes. The ability to successfully transplant the hematopoietic cells of the bone marrow may provide a way to establish tolerance to islets from multiple donors without the need for long-term immunosuppression.

Project Start
1997-05-01
Project End
1998-04-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Li, Jinzhu; Ridgway, William; Fathman, C Garrison et al. (2007) High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis. J Neuroimmunol 192:57-67
Krieger, N R; Fathman, C G; Shaw, M K et al. (2000) Identification and characterization of the antigen-specific subpopulation of alloreactive CD4+ T cells in vitro and in vivo. Transplantation 69:605-9
Gandy, K L; Weissman, I L (1998) Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells. Transplantation 65:295-304
Ridgway, W; Fasso, M; Fathman, C G (1998) Following antigen challenge, T cells up-regulate cell surface expression of CD4 in vitro and in vivo. J Immunol 161:714-20
Ito, H; Fathman, C G (1997) CD45RBhigh CD4+ T cells from IFN-gamma knockout mice do not induce wasting disease. J Autoimmun 10:455-9
Krieger, N R; Fathman, C G (1997) The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection. J Heart Lung Transplant 16:263-7
Krieger, N R; Ito, H; Fathman, C G (1997) Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice. J Autoimmun 10:309-15
Yang, Y; Charlton, B; Shimada, A et al. (1996) Monoclonal T cells identified in early NOD islet infiltrates. Immunity 4:189-94
Ridgway, W M; Fasso, M; Lanctot, A et al. (1996) Breaking self-tolerance in nonobese diabetic mice. J Exp Med 183:1657-62
Shimada, A; Charlton, B; Taylor-Edwards, C et al. (1996) Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 45:1063-7

Showing the most recent 10 out of 20 publications